N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
US8183381B2 · kind B2 · utility
11Cited by
18References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2008 |
| Grant date | May 22, 2012 |
| Priority date | — |
| Expiry date | Aug 4, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.